Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

Google partners with Bayer on new AI product for radiologists

Apr 10, 2024 - cnbc.com
Google Cloud and German healthcare company Bayer are developing an AI-powered platform to assist radiologists in diagnosing patients and processing cases more efficiently. The platform uses generative AI to highlight anomalies in images and can pull up relevant information from a patient's medical history. The technology aims to alleviate the labor shortage in the radiology field by increasing efficiency and reducing the time spent on searching through patient records.

The platform, which has been in development for five years, does not aim to replace radiologists but to assist them, akin to a microscope. Other companies, such as Philips and Amazon Web Services, are also exploring AI applications for medical imaging. The platform represents a new business model for Bayer, which generated around €2 billion (US$2.16 billion) in sales from its radiology products last year. The companies are exploring different pricing models for the platform, which will begin testing with other healthcare organizations this year.

Key takeaways:

  • Google Cloud and German health-care company Bayer are developing an AI-powered platform to assist radiologists in diagnosing patients and working through cases more efficiently.
  • The platform uses generative AI to flag anomalies in images and can pull up relevant information from a patient's medical history. It does not replace radiologists but serves as an assistive tool.
  • Other companies, including Philips and Amazon Web Services, are also exploring AI applications for medical imaging. However, the technology is still new and the market leader is not yet clear.
  • Google Cloud and Bayer have been working on the radiology platform for around five years, and it represents a new business model for Bayer. Other health-care organizations will begin testing and providing feedback on the platform this year.
View Full Article

Comments (0)

Be the first to comment!